NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/06/2025
Voltar para busca
Dado oficial do USPTO
ALLISON INSTITUTE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ALLISON INSTITUTE
ST13
US500000097975242Classe
35, 36, 42, 44
Pedido
97975242
Registro
7845095
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
24/06/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 44
Data de depósito
25/03/2022
Data de registro
24/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/06/2025
Última transação
24/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
14/11/2023
Primeiro uso no comércio
14/11/2023
Código do desenho
4
Tipo de titular
14
Localização do titular
Austin, TX, US
Examinador
GLUECK, CHRISTOPHER
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
The Board of Regents of the University of Texas System
Representantes
Robin Lightner Maisashvili FIBBE LIGHTNER LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting collaboration within the scientificresearchpharmaceuticalmedical communities to achieve advances in healthcareincluding to accelerate the development and use of immunotherapy in treatment of disease
Classe 36
Charitable fundraising services
Classe 42
Medical research services; medical researchdevelopmenttechnical designtestinganalysis services in the field of immunobiologyimmunotherapyantibodiesoncology; consulting services in the field of immunobiologyimmunotherapyantibodiesoncology; medical research and development of antibodiestherapeutic productsvaccinesimmunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiologyimmunotherapyantibodies and oncology; biological research; laboratory research services in the fields of immunobiologyimmunotherapyantibodiesoncologycellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell researchcancerimmunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison servicesconsulting in the field of scientific research pertaining to clinical trials in the fields of health caremedicineimmunobiologyimmunotherapypharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; Pharmaceutical research services; Pharmaceutical research services relating to cancer
Classe 44
Medical services; Medical services relating to cancer; providing medical information; providing health information in the field of immunobiologyimmunotherapyoncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiologyimmunotherapyoncology and diseases; providing medical informationconsultancy and advisory services; providing information on cancer treatment; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/06/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/05/2025
IUAF
USE AMENDMENT FILED
05/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/04/2025
EX4G
SOU EXTENSION 4 GRANTED
23/04/2025
EXT4
SOU EXTENSION 4 FILED
16/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
16/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/10/2024
EX3G
SOU EXTENSION 3 GRANTED
17/10/2024
EXT3
SOU EXTENSION 3 FILED
17/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
17/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/04/2024
EX2G
SOU EXTENSION 2 GRANTED
11/04/2024
EXT2
SOU EXTENSION 2 FILED
11/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/04/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13/10/2023
EX1G
SOU EXTENSION 1 GRANTED
11/10/2023
EXT1
SOU EXTENSION 1 FILED
11/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/02/2023
PUBO
PUBLISHED FOR OPPOSITION
21/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/01/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
11/01/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/01/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
11/01/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/01/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
12/12/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/12/2022
DRRR
DIVISIONAL REQUEST RECEIVED
01/11/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/11/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
29/08/2022
GNRT
NON-FINAL ACTION E-MAILED
29/08/2022
CNRT
NON-FINAL ACTION WRITTEN
29/08/2022
DOCK
ASSIGNED TO EXAMINER
25/08/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/03/2022
NWAP
NEW APPLICATION ENTERED
29/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALLISON INSTITUTE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.